HomeCompareSHZUY vs MRK

SHZUY vs MRK: Dividend Comparison 2026

SHZUY yields 5.28% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHZUY wins by $17.9K in total portfolio value
10 years
SHZUY
SHZUY
● Live price
5.28%
Share price
$60.96
Annual div
$3.22
5Y div CAGR
26%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74.7K
Annual income
$15,911.07
Full SHZUY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SHZUY vs MRK

📍 SHZUY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHZUYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHZUY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHZUY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHZUY
Annual income on $10K today (after 15% tax)
$449.00/yr
After 10yr DRIP, annual income (after tax)
$13,524.41/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SHZUY beats the other by $5,196.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHZUY + MRK for your $10,000?

SHZUY: 50%MRK: 50%
100% MRK50/50100% SHZUY
Portfolio after 10yr
$65.7K
Annual income
$12,854.60/yr
Blended yield
19.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SHZUY
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHZUY buys
0
MRK buys
0
No recent congressional trades found for SHZUY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHZUYMRK
Forward yield5.28%2.76%
Annual dividend / share$3.22$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR26%32.7%
Portfolio after 10y$74.7K$56.8K
Annual income after 10y$15,911.07$9,798.13
Total dividends collected$47.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SHZUY vs MRK ($10,000, DRIP)

YearSHZUY PortfolioSHZUY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,366$665.57$11,206$366.19+$160.00SHZUY
2$13,052$890.78$12,650$502.35+$402.00SHZUY
3$15,170$1,204.60$14,407$694.19+$763.00SHZUY
4$17,881$1,648.71$16,585$967.82+$1.3KSHZUY
5$21,421$2,288.38$19,342$1,363.89+$2.1KSHZUY
6$26,149$3,228.23$22,913$1,947.19+$3.2KSHZUY
7$32,619$4,640.48$27,662$2,823.89+$5.0KSHZUY
8$41,720$6,816.76$34,159$4,173.35+$7.6KSHZUY
9$54,907$10,266.63$43,337$6,308.80+$11.6KSHZUY
10$74,661$15,911.07$56,776$9,798.13+$17.9KSHZUY

SHZUY vs MRK: Complete Analysis 2026

SHZUYStock

The Shizuoka Bank, Ltd., a regional bank, provides various banking products and services. The company operates through Banking Operations and Leasing Operations segments. The Banking Operations segment consist of the banking business centered on deposits, loans, investment securities, and exchange transactions. The Leasing Operations segment includes lease transactions centered on finance leases. It also provides corporate and financial management advisory, bill collection, leasing, and finance and securities-related services. In addition, the company engages in the guarantee of housing loans, credit cards and prepaid cards, and consumer loans; development and operation of computer systems; provision of public-offering assistance support for corporate rehabilitation, and fee-based job placement and general administration services; and appraisal of real estate for loan collateral, as well as operation of centers for loans, remittance, and bill collection. Further, it is involved in the provision of part-time employee management, finance and securities-related, and monetary receivables purchasing services; and making, printing, and binding of various documents. As of July 1, 2021, the company operated a head office, 178 branches, and 27 sub-branches in Shizuoka Prefecture, Tokyo, Osaka, and Nagoya; 2 branches in New York and Los Angeles; 1 in Europe; and 1 branch in Hong Kong, as well as 2 representative offices in Shanghai and Singapore. The Shizuoka Bank, Ltd. was founded in 1943 and is headquartered in Shizuoka, Japan.

Full SHZUY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SHZUY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHZUY vs SCHDSHZUY vs JEPISHZUY vs OSHZUY vs KOSHZUY vs MAINSHZUY vs JNJSHZUY vs ABBVSHZUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.